Learn more about the formula tested in the Case study.
featuring Nate Lighthizer, OD, FAAO
Diabetes is a common disease that can have a potent effect on the retina. Eye care providers can objectively evaluate retinal function using Diopsys® ffERG/Flicker vision tests, potentially catching deficiencies of the retina even before vascular abnormalities develop.1-4 Once identified, dysfunction may then be improved by EyePromise® DVS nutritional supplements.5-6
DVS (Diabetes Visual Support) is the only clinically proven nutraceutical to improve visual function in patients with diabetes. As an ideal early intervention tool, DVS gives eye care providers an additional tool that’s specifically designed for a patient that’s at risk of or currently has irreversible diabetic eye damage.
Please watch Dr. Lighthizer discuss the need for objective, functional testing of the retina and the use of supplements in diabetic patients to help you identify, track, and respond to vision problems sooner.
Interested in downloading the .pdf Case Study?
Nate Lighthizer, OD, FAAODr. Nathan Lighthizer is a graduate of Pacific University College of Optometry. Upon graduation, he completed a residency in Family Practice Optometry with an emphasis in Ocular Disease through Northeastern State University Oklahoma College of Optometry. Dr. Lighthizer has since joined the faculty at the Oklahoma College of Optometry and serves as an Associate Professor, Assistant Dean of Clinical Care Services, Director of Continuing Education and Chief of Specialty Care Clinics.
Dr. Lighthizer lectures nationally on numerous topics, most notably advanced ophthalmic procedures, electrodiagnostics, and ocular disease.
To have an EyePromise Representative reach out to you please complete the form below.
To have a Diopsys Representative reach out to you please call 973-244-0622 or email info@diopsys.com.
This webinar video represents the experiences and opinions of Nate Lighthizer, OD, FAAO. Physicians should make medical decisions based on the individual facts and history of each patient. Originally presented on November 19, 2019.
DVS: Additional Supporting Science
The Diabetes Visual Function Supplement Study (DiVFuSS) was designed to test the effects of a novel, multi-component nutritional supplement (DVS) on visual function. Participants included patients with both type 1 and type 2 diabetes.
DiVFuSSstudy results showed significant improvements in visual function for patients with diabetes without effecting blood sugar levels.
Who Should Take DVS?
Benefits to Your Practice
1. Wroblewski, John J., et al. Reproducibility of Fixed-Luminance and Multi-Luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-Based Testing Paradigm. Journal of Diabetes Science and Technology, Oct. 2019, doi:10.1177/1932296819882719. 2. Holm K, et al. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema. Doc Ophthalmol. 2015;131:43-51. 3. Pescosolido N, et al. Role of Electrophysiology in the Early Diagnosis and Follow-Up of Diabetic Retinopathy. J Diabetes Res. 2015;doi.org/10.1155/2015/319692. 4. Tzekov R, et al. The Electroretinogram in Diabetic Retinopathy Surv Ophthalmol. 1999;doi:10.1016/s0039-6257(99)00063-6. 5. Chous AP, et al. The Diabetes Visual Function Supplement Study (DiVFuSS). Br J Ophthalmol. 2016;doi:10.1136/bjophthalmol-2014-306534. 6. Kowluru RA, et al. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab. 2014;doi:10.1186/1743-7075-11-8.
